Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Carcinoma Stage III”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Not applicableActive Not RecruitingNCT04678414
What this trial is testing

Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+27 more
M.D. Anderson Cancer Center 1,410
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03367741
What this trial is testing

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
National Cancer Institute (NCI) 82
Not applicableStudy completedNCT01098630
What this trial is testing

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more
Gynecologic Oncology Group 778
Not applicableStudy completedNCT03466788
What this trial is testing

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

Who this might be right for
Endometrial CancerChemotherapy EffectQuality of Life
Centre Francois Baclesse 51
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT00258362
What this trial is testing

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00513786
What this trial is testing

Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
David O'Malley 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03008408
What this trial is testing

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRefractory Endometrial Carcinoma+10 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Ended earlyNCT02112552
What this trial is testing

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Who this might be right for
Endometrial Serous AdenocarcinomaStage IIIA Uterine Corpus CancerStage IIIB Uterine Corpus Cancer+4 more
Albert Einstein College of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00002949
What this trial is testing

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Who this might be right for
Bladder CancerCervical CancerEndometrial Cancer+1 more
University of Chicago 33
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Large-scale testing (Phase 3)Ended earlyNCT00577317
What this trial is testing

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Who this might be right for
LymphedemaStage 0 Cervical CancerStage 0 Uterine Corpus Cancer+16 more
Gynecologic Oncology Group 2
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT05524389
What this trial is testing

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Who this might be right for
Endometrial CancerAdjuvant RadiotherapyMolecular Classification
Peking Union Medical College Hospital 624
Early research (Phase 1)Study completedNCT00004082
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Beth Israel Deaconess Medical Center
Load More Results